The Leukotriene Modifier Or Corticosteroid or Corticosteroid-Salmeterol Trial
Public ClinicalTrials.gov record NCT00156819. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This research study will compare the treatment effects of three different asthma medications in asthma subjects whose asthma is well controlled when they take fluticasone, an inhaled corticosteroid. The treatments are fluticasone, montelukast (an anti?leukotriene drug), and a combination therapy of fluticasone and salmeterol (a long-acting beta-agonist). Fluticasone, montelukast, and the combination therapy of fluticasone and salmeterol (Advair Diskus®) are all approved for the treatment of asthma. We are looking at whether the three treatments are equally effective for reducing the number and the severity of asthma attacks in subjects with mild to moderately severe asthma.
Study identification
- NCT ID
- NCT00156819
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 31, 2003
- Primary completion
- Jul 31, 2005
- Completion
- Jul 31, 2006
- Last update posted
- Dec 8, 2015
2003 – 2006
United States locations
- U.S. sites
- 19
- U.S. states
- 15
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35233 | — |
| National Jewish Hospital | Denver | Colorado | 80206 | — |
| Nemour's Childrens Center | Jacksonville | Florida | 32207 | — |
| University of Miami (and University of South Florida in Tampa) | Miami | Florida | 33136 | — |
| Emory University | Atlanta | Georgia | 30322 | — |
| Illinois Consortium (Northwestern, Univ. of Chicago, Univ. of Illinois) | Chicago | Illinois | 60611 | — |
| Indiana University | Indianapolis | Indiana | 46202 | — |
| Louisiana State University | New Orleans | Louisiana | 70112 | — |
| University of Minnesota | Minneapolis | Minnesota | 55455 | — |
| University of Missouri at Kansas City | Kansas City | Missouri | 64108 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Long Island Jewish Hospital (and North Shore Hospital) | New Hyde Park | New York | 11040 | — |
| New York Consortium (New York Univ. and Columbia Univ.) | New York | New York | 10016 | — |
| New York Medical College | Valhalla | New York | 10595 | — |
| Duke University School of Medicine | Durham | North Carolina | 27710 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Thomas Jefferson Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Northern New England Consortium (Univ. of Vermont and other locations) | Burlington | Vermont | 05405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00156819, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 8, 2015 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00156819 live on ClinicalTrials.gov.